- Home
- Life Sciences
- Biotechnology
- Biopharmaceutical
- Emerging Tumor Markers: New Assays and Companies Developing Innovative Technologies and Products
Biopharmaceutical
Summary
Table of Contents
HighlightsComprehensive 260-page market and technological assessment.Medical rationale and diagnostic prospects for major categories of both circulating and cellular tests, such as : - Biochemical Markers- Oncogenes- Growth Factors- Hormones - Colony Stimulating Factors - Lymphokines - Immunohistochemical Stains. Overview of the clinical significance and market needs...
More »Search ReportLinker
The Largest Collection of Market Research Reports
» 450,000 Company Profiles
» 40,000 Country Guides
From +200,000 authoritative sources
Talk to Alison
00 1 718 618 48 97
Biopharmaceutical Industry : Latest Reports
Analytical Tool - Antibodies and Peptides in Oncology
- $ 8 925
- Industry report
- April 2013
- by Bioseeker
"Analytical Tool - Antibodies and Peptides in Oncology" offers a unique tool for analyzing the vast amount of strategic possibilities that have emerged in R&D and business development in the antibody and ...
![Protein Engineering Market [Products (Monoclonal Antibody, Insulin Analog, Modified EPO), Technology (Sequential Modification, Glycosylation, PEGylation), and Applications (Therapeutics, Diagnostics, Research)] - Global Forecast to 2017](https://d99ngkg9mjpdb.cloudfront.net/public/images/pub/1329.gif)
Protein Engineering Market [Products (Monoclonal Antibody, Insulin Analog, Modified EPO), Technology (Sequential Modification, Glycosylation, PEGylation), and Applications (Therapeutics, Diagnostics, Research)] - Global Forecast to 2017
- $ 4 650
- Industry report
- March 2013
- by MarketsandMarkets
Proteins exhibit high specificity and less immunogenicity and are widely used as therapeutic agents in the treatment of various disorders and diseases. There are more than 200 protein-based products currently ...
Triple Analysis: Cancer Vaccines, Antibodies and Peptides
- $ 5 175
- Industry report
- March 2013
- by Bioseeker
This triple analysis focuses on cancer drug development strategies by the mechanism/target/effect of Cancer Vaccines and by the two compound strategies of Antibodies and Peptides. Each of these three individual ...
More Reports:
Biopharmaceutical in China (12)
Biopharmaceutical Industry : Latest Downloads
Enzyme Sector Analysis
- Industry report
- March 2013
- 90 pages
... Production Preparation of enzymes 21/03/2013 why enzymes Catalysts increase the rate of reactions without any net change in their structure. Concept of catalysis is developed as early as the 19th ...
Biopharmaceutical Industry Brief
- Industry report
- October 2012
- 8 pages
... Alfa was non-inferior to imiglucerase if the lower limit of the one-sided 97.5% Confidence interval (ci) of the treatment difference (velaglucerase alfa minus imiglucerase) was greater than -1 g ...
Biopharmaceutical Sector Brief
- Industry report
- October 2012
- 6 pages
... E in upstream and downstream development. As an example of pharmaceutical proteins whole production processes of potential malaria vaccines are investigated in detail. In the field of technical enzymes ...
World Biopharmaceutical Industry Overview
8 months agoAntibody Market Brief
8 months agoBiopharmaceutical : Innovation And Technology ...
8 months agoBiopharmaceutical Market Brief
9 months agoBiosimilar Sector Brief
9 months agoBioprocessing Business Brief
9 months agoBiopharmaceutical Sector Brief
10 months agoMore Reports:
Biopharmaceutical in Australia (8)
Company Reports
Company Profiles
10 CompaniesThomson Financial Gmbh
GermanyRoche Holding AG
SwitzerlandBASF SE
GermanyRXi Pharmaceuticals Corp.
United StatesJMP Group Inc.
United StatesJMP Securities L.L.C.
United StatesCowen Group Inc.
United StatesSynta Pharmaceuticals Corp.
United StatesGeneral Electric Co.
United StatesWarner Chilcott P.L.C.
United Statesref:plp2011
Reportlinker.com © Copyright 2013. All rights reserved.
